2 Expensive Stocks I’d Avoid Before a Rotation Out of Tech Stocks

Shopify Inc. (TSX:SHOP)(NYSE:SHOP) and another frothy tech stock are riding high on pandemic tailwinds. I think they could be at risk of a big correction.

| More on:

Whenever you have a stock that turns into a multi-bagger in a matter of months, you should start thinking about taking at least a bit of profit off the table. While there’s a possibility that you could miss out on further gains, or perhaps a rally that causes shares to double again, there’s also a chance that you could stand to surrender a chunk of the gains to Mr. Market in a violent reversal of momentum.

While I am a believer that newfound tailwinds and positive developments are worthy of abrupt multiple expansion, investors ought to be careful that euphoria from a rally doesn’t cause one to ignore the valuation. Whether on a historical or relative basis, valuation always matters. And if a stock has run above and beyond your original gauge of intrinsic value, it may be time to do some trimming.

The following two Canadian stocks, I believe, are starting to look way too expensive and could leave new buyers at risk of facing amplified downside if a sudden reversal of momentum were to occur. Now, the following stocks may have firms with wonderful business models and unprecedented tailwinds, but the valuation, I think, has grown a tad too frothy for my liking as a value investor.

Shopify

To say Shopify (TSX:SHOP)(NYSE:SHOP) is a wonderful business would be a vast understatement. It’s arguably the second-best e-commerce company on the planet behind Amazon.com. The stock has continued to defy short-sellers and value-oriented investors thanks in part to the iconic founder Tobias Lütke, who somehow keeps finding a way to raise the bar to justify a higher multiple.

The company has been firing on all cylinders, and to the awe of many, it not only demonstrated resilience amid the coronavirus crisis; it also rode high on tailwinds produced by the crisis. There’s no question that the company is deserving of a considerable amount of multiple expansion over the years, as the fundamentals keep getting better and better. Lütke and company put churn concerns to rest, and short-sellers are now licking their wounds, as Shopify went on to soar above and beyond the $1,000 mark to become Canada’s most valuable company by market cap.

As you can tell from my tone, I’m a huge fan of Shopify the business. What I’m not a fan of is the valuation. Sure, the stock has never been anything short of absurdly expensive, but with a 64 times sales multiple, the stock could get cut in half and still be more expensive than most growth stocks out there on a price-to-sales basis. In the meantime, Shopify will continue killing it, as it profits off the continued shift to e-commerce that’s been profoundly accelerated by government-mandated shutdowns and quarantines.

Docebo

Docebo (TSX:DCBO) is another high-flying tech stock that’s been benefiting from pandemic tailwinds this year. The e-learning kingpin is largely unknown by Wall and Bay Street, but that could change, as the demand for learning management system (LMS) software increases in conjunction with the work-from-home trend.

I’ve been pounding the table on Docebo in the past, but with shares more than tripling in a matter of months, it may be a wise idea to take some profits, because a reversal in momentum for the stock and the broader tech industry could have the potential to be vicious.

Docebo shares, alongside most other recent winners, have taken a small dip in recent weeks. Although the stock is cheaper than it was last week, it’s not significantly cheaper, with shares at 18 times sales and 28.5 times book value. For now, Docebo will continue making the most of its fortunate positioning in the niche LMS industry. And while I’m a fan of the long-term growth story, I’d prefer to wait for a meaningful pullback before I’d consider buying the white-hot stock that’s exhibited stronger momentum than the likes of Shopify of late.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of and recommends Shopify and Shopify.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »